| 1741 |
Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience |
Department of Rheumatology ,Rehabilitation & physical medicine |
2020 |
| 1742 |
Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience |
Department of Rheumatology ,Rehabilitation & physical medicine |
2020 |
| 1743 |
Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience |
Department of Rheumatology ,Rehabilitation & physical medicine |
2020 |
| 1744 |
Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience |
Department of Rheumatology ,Rehabilitation & physical medicine |
2020 |
| 1745 |
Impact of comorbidities on COVID-19 outcome |
Department of Microbiology and Immunology |
2020 |
| 1746 |
Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus |
Department of Microbiology and Immunology |
2020 |
| 1747 |
Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus |
Department of Gastroenterology and Tropical Medicine |
2020 |
| 1748 |
Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus |
Department of Microbiology and Immunology |
2020 |
| 1749 |
Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus |
Department of Microbiology and Immunology |
2020 |
| 1750 |
Impact of Secondary Aortic Interventions After Thoracic Endovascular Aortic Repair on Long-Term Survival |
Department of Cardio-Thoracic Surgery |
2020 |